BGM Group Stock Price, News & Analysis
Company Description
BGM Group Ltd. (NASDAQ: BGM) is a healthcare and technology company with a strategic focus that spans biopharmaceuticals, artificial intelligence (AI) applications, intelligent robots, algorithmic computing power, and cloud computing. The company is associated with the drug manufacturers – specialty and generic industry through its biopharmaceutical activities, while also building a broad AI-driven technology ecosystem.
According to company disclosures, BGM’s business combines traditional pharmaceutical production with AI-enabled platforms and services. The group highlights a strategy around a "multi-agent AI productivity platform" and AI Agent technology, which it applies across areas such as insurance, mobility, and digital services, alongside its established biopharmaceutical operations.
Biopharmaceutical and Healthcare Operations
BGM’s biopharmaceutical division mainly produces oxytetracycline active pharmaceutical ingredient (API), crude heparin sodium, and licorice preparations. These products are described as being supplied to the global animal husbandry, pharmaceutical, and drug retail markets. The company states that it integrates AI-assisted decision-making into production and manufacturing, aiming for supply chain optimization, process efficiency improvement, and market trend prediction in this division.
Public information also notes that BGM has been active in healthcare-related product expansion. Through an agreement to acquire Wonder Dragon Global Limited, which holds premium Qingzhuan dark tea inventory, BGM describes a plan to advance a "medicine + tea + health" product ecosystem. The company has referenced medicinal tea product development and the use of its biotechnology and AI decision-making platforms to support health-focused tea products.
AI Applications in Insurance and Financial Services
BGM states that it has a strategic focus on AI applications for the insurance industry. The group relies on big data mining, advanced analytics, and AI Agent technology, and utilizes two named platforms, Du Xiao Bao and Bao Wang. Based on company descriptions, these platforms are used to provide AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers.
The services described by BGM cover multiple scenarios in the insurance value chain, including sales and marketing, underwriting assessment, claims processing, and customer service. The group states that it can analyze consumer data, build consumer profiles, predict insurance needs, and provide customized services for consumers through these AI tools. BGM has also announced the establishment of a Duxiaobao Management Committee to oversee the "Duxiaobao" ecosystem, which it characterizes as part of its strategic entry into artificial intelligence and the intelligent transformation of the insurance industry.
Through acquisitions of entities such as Rongshu Technology and Xinbao Investment Company, described as subsidiaries of AIX Corp., BGM has linked its AI capabilities to insurance and healthcare-related services. Company communications describe these steps as part of a shift from traditional pharmaceutical operations toward AI-driven insurance and health businesses.
AI, Intelligent Robots, and Multi-Agent Platforms
BGM has repeatedly emphasized a broader AI strategy beyond insurance. The company describes a focus on AI application, intelligent robots, algorithmic computing power, and cloud computing. It has announced agreements to acquire Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. and YD Network Technology Company Limited, subject to closing conditions.
According to BGM, Xingdao Intelligent is a manufacturer and operator of embodied service robots with proprietary robotic hardware systems and foundational algorithms. The company’s disclosures state that Xingdao Intelligent has a significant patent base in service robotics and applies its products in industries such as restaurant services, retail malls and supermarkets, building management, hospitals, and industrial inspections. BGM presents this acquisition as a way to integrate hardware and software and complete a "perception-understanding-execution" cycle in real-world AI applications.
YD Network is described by BGM as a company dedicated to intelligent stock trading through AI, using proprietary financial models and quantitative algorithms. The services mentioned include intelligent stock selection, trading strategy optimization, and risk management for various investors. BGM positions this transaction as an expansion of its AI capabilities into the fintech sector and part of building a cross-industry intelligence ecosystem covering marketing, labor, and capital markets.
BGM has also announced an agreement to acquire HM Management Company Limited, an AI agent production platform, along with its subsidiaries Beijing Shuda Technology Company Limited and New Media Star Technology (Shenzhen) Co., Ltd.. Shuda Technology is described as specializing in AI-driven enterprise efficiency solutions and integrated AI and data visualization tools for business diagnostics and decision-making. New Media Star is described as operating an AI tools platform with a substantial follower base and offering proprietary and third-party AI solutions for customer acquisition and private domain conversion. BGM links these assets to its goal of building a multi-agent production platform and expanding industry-specific AI modules.
Intelligent Mobility and Platform Strategy
BGM has disclosed an acquisition of YX Management Company Ltd., described as an intelligent or smart mobility technology platform. The company indicates that YX contributes expertise in scalable operations, digital infrastructure, and technology commercialization. BGM connects this acquisition to the evolution of its intelligent platform, including the DuXiaoBao ecosystem, and to deeper integration of AI into areas such as intelligent insurance, intelligent mobility, and digital services.
Across these activities, BGM characterizes its direction as building a multi-agent AI productivity platform and an AI workforce platform. Public statements describe a matrix of capabilities that includes AI-powered marketing, AI workforce platforms, AI-driven industry applications, and AI infrastructure, with the aim of offering more efficient and scalable AI-based services to clients.
Corporate Evolution and Governance
BGM Group Ltd. is listed on NASDAQ under the ticker symbol BGM. Company communications refer to its history in pharmaceuticals and chemicals and to its listing on NASDAQ as a milestone in its development. More recent disclosures emphasize a strategic transformation toward AI technology, insurance technology, and diversified growth that connects healthcare, pharmaceuticals, and insurance.
The company has announced changes in its board of directors and leadership structure in connection with this transformation, including a transition in the chairmanship and the appointment of directors with backgrounds in AI algorithms, intelligent driving, and deep learning network theory. BGM presents these governance changes as part of its move into a new phase of technological transformation and strategic upgrade.
Business Segments and Strategic Themes
Based on company descriptions, BGM’s activities can be viewed across several themes:
- Biopharmaceuticals and healthcare – production of oxytetracycline API, crude heparin sodium, and licorice preparations, and initiatives around medicinal tea and health products.
- AI insurance and financial services – AI Agent-based platforms such as Du Xiao Bao and Bao Wang for insurance-related scenarios, and AI-driven insurance brokerage and stock trading services through acquisitions.
- Intelligent robots and embodied AI – service robotics hardware and software through Xingdao Intelligent, aimed at real-world service environments.
- Intelligent mobility and digital platforms – integration of smart mobility technology and large-scale platform operations through YX and the DuXiaoBao ecosystem.
- AI infrastructure and enterprise solutions – algorithmic computing, cloud computing, and enterprise AI efficiency tools through entities such as Shuda Technology.
Across these areas, BGM’s public materials consistently highlight the integration of AI with existing industries such as pharmaceuticals, insurance, mobility, and healthcare-related products.
Stock Performance
BGM Group (BGM) stock last traded at $0.4600, down 7.24% from the previous close. Over the past 12 months, the stock has lost 96.1%. At a market capitalization of $94.3M, BGM is classified as a micro-cap stock with approximately 200.5M shares outstanding.
Latest News
BGM Group has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, earnings, acquisition, AI. View all BGM news →
SEC Filings
BGM Group has filed 1 recent SEC filing, including 1 Form 6-K. The most recent filing was submitted on January 29, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BGM SEC filings →
Financial Highlights
BGM Group generated $25.1M in revenue over the trailing twelve months, retaining a 16.4% gross margin, operating income reached -$564K (-2.3% operating margin), and net income was -$1.4M, reflecting a -5.8% net profit margin. Diluted earnings per share stood at $-0.20. The company generated $544K in operating cash flow. With a current ratio of 3.39, the balance sheet reflects a strong liquidity position.
Upcoming Events
Nasdaq compliance deadline
BGM Group has 1 upcoming scheduled event. The next event, "Nasdaq compliance deadline", is scheduled for August 17, 2026 (in 140 days). Investors can track these dates to stay informed about potential catalysts that may affect the BGM stock price.
Short Interest History
Short interest in BGM Group (BGM) currently stands at 67.4 thousand shares, down 4.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 95.5%. This relatively low short interest suggests limited bearish sentiment. With 10.7 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for BGM Group (BGM) currently stands at 10.7 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 969% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 16.3 days.
BGM Company Profile & Sector Positioning
BGM Group (BGM) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing BGM often look at related companies in the same sector, including Harrow Health Inc (HROW), Phibro Animal (PAHC), Avadel Pharmaceu (AVDL), Amphastar Pharma (AMPH), and Biocryst Pharmaceuticals Inc (BCRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BGM's relative position within its industry.